http://www.abbs.info e-mail:abbs@sibs.ac.cn

ISSN 0582-9879                                          ACTA BIOCHIMICA et BIOPHYSICA SINICA 2003, 35(8): 702¨C706                                    CN 31-1300/Q

Assessment of the Escherichia coli Tat Protein Translocation Systemwith Fluorescent Proteins

ZHANG Ming1,2,3, PAN Ren-Rui1, YU Zeng-Liang1,WU Long-Fei2*

( 1 Key Lab of Ion Beam Bioengineering, Institute of Plasma Physics, the Chinese Academy of Sciences, Hefei 230031, China; 2 Laboratoire de Chimie Bact¨¦rienne, UPR9043 CNRS, 31 chemin Joseph Aiguier, 13402 Marseille cedex 20, France; 3 College of Life Science, Anhui Agricultural University, Hefei 230036, China )

 

Abstract        The possibility of using fluorescent proteins as probes to study the twin-arginine translocation (Tat) system was assessed in Escherichia coli. When fused to the twin-arginine signal peptide of trimethylamine N-oxide reductase, the DsRed2 red fluorescent protein from the Discosoma sp. was successfully synthesized and folded in E. coli cells. However, RR-DsRed2 aggregated inside the cells. Therefore, although DsRed2 has been engineered from DsRed for faster maturation and lower non-specific aggregation, it is still not compatible with Tat-dependent translocation. In contrast, the jellyfish green fluorescent protein (GFP) was efficiently exported into periplasm even when the RR motif was changed to KR or RK. These results show that GFP can be used as an efficient reporter protein to study Tat system, but DsRed2 is not suitable for such purpose because of its aggregation property. In addition, when the protein concentration was similar, the fluorescence intensity of KR-GFP and RK-GFP decreased compared with RR-GFP, which would suggest that the twin-arginine signal peptide is not only essential for mediating protein translocation, but also important for the folding of down-stream protein.

 

Key words     fluorescent protein; report protein; Tat protein translocation; signal peptide; protein folding

________________________________________

Received: April 7, 2003         Accepted: May 20, 2003

This work was supported by the grants from INCO Bursary (No. ICB1-CT-2000-80014), and the Outstanding Overseas Chinese Scholars Fund of Chinese Academy of Sciences (No. 2003-1-5)

*Corresponding author: Tel, +33-491164517; Fax, +33-491718914; e-mail, wu@ibsm.cnrs-mrs.fr

 

ÀûÓÃÓ«¹âµ°°×¶Ô´ó³¦¸Ë¾úµ°°×ÖÊTatתÔËϵͳµÄÑо¿

ÕÅÃ÷1,2,3    ÅËÈÊÈð1   ÓàÔöÁÁ1   ÎâÁú·É2*

( 1Öйú¿ÆÑ§ÔºµÈÀë×ÓÌåÎïÀíÑо¿ËùÀë×ÓÊøÉúÎ﹤³ÌÖØµãʵÑéÊÒ, ºÏ·Ê 230031; 2·¨¹ú¹ú¼Ò¿ÆÑ§Ñо¿ÖÐÐÄϸ¾ú»¯Ñ§Ñо¿ÊÒ, ÂíÈü 13402 cedex 20; 3°²»Õũҵ´óѧÉúÃü¿ÆÑ§Ñ§Ôº, ºÏ·Ê 230036 )

 

ÕªÒª       ̽ÌÖÁËÓ«¹âµ°°××÷Ϊ±¨¸æµ°°×ÓÃÓÚµ°°×ÖÊתÔËϵͳÑо¿µÄ¿ÉÐÐÐÔ, ½á¹û±íÃ÷º£¿ûºìɫӫ¹âµ°°×¾Û¼¯ÔÚϸ°ûÖÊÄÚ, ²»ÄÜתÔËÖÁÖÜÖʿռ䡣 ¶øË®Ä¸ÂÌɫӫ¹âµ°°×ÔÚTatÐźÅëĺÍTatתÔËøµÄ¹²Í¬×÷ÓÃÏÂ, ÒÔÕÛµþÐÎʽתÔËÖÁÖÜÖʿռ䡣 ͨ¹ýÓ«¹â¶¨Á¿·ÖÎö±íÃ÷ÐźÅëı£ÊØÐòÁÐÖеÄË«¾«°±ËáÊDZ£Ö¤ÂÌɫӫ¹âµ°°×תÔ˼°×ªÔËЧÂÊËù±ØÐèµÄ, ÇÒµÚ¶þ¸ö¾«°±Ëá±ÈµÚÒ»¸ö¾«°±Ëá¸üÎªÖØÒª¡£ ͬʱ, ½ÒʾÁËTatÐźÅëÄÐèÒªÒ»¶¨µÄ¸ß¼¶½á¹¹²ÅÄÜÐÐʹ¹¦ÄÜ; TatÐźÅëIJ»½öÒýµ¼µ°°×ÖʵÄתÔË, ¶øÇÒÒ²²ÎÓëµ°°×ÖʵÄÕÛµþ¡£ Òò´Ë, ÂÌɫӫ¹âµ°°×ÊǷdz£ÀíÏëµÄ±¨¸æµ°°×, ¿ÉÓÃÓÚÑо¿Tatϵͳ, µ«ÊǺ£¿ûºìɫӫ¹âµ°°×Ò×ÓÚ¾Û¼¯¶ø²»ÊʺÏÓÚ´ËÄ¿µÄ¡£

 

¹Ø¼ü´Ê   Ó«¹âµ°°×; ±¨¸æµ°°×; TatתÔËϵͳ; ÐźÅëÄ; µ°°×ÖÊÕÛµþ

 

ϸ¾úµ°°×ÖÊTatתÔËϵͳÊÇ1998ÄêÔڴ󳦸˾úÖз¢ÏÖµÄÒ»ÖÖµ°°×ÖÊתÔËϵͳ, Òò±»×ªÔ˵ĵ×ÎïÐźÅëÄÉϺ¬ÓÐË«¾«°±Ëá(RR)±£ÊØÐòÁкËÐÄS/T-R-R-x-F-L-K[1¡«9], ËùÒÔ³ÆÎªTat (twin-arginine translocation)תÔËϵͳ¡£ ÕâЩµ×ÎïÊÇһЩÓëϸ¾úÑáÑõºôÎüºÍϸ¾ú·ÖÁÑÓйصÄø»òµ°°×ÖÊ, ËùÒÔTatתÔËϵͳÓëϸ¾úµÄÉúÃü»î¶¯ÓÐ×ÅÊ®·ÖÃÜÇеĹØÏµ¡£ µ×Îïµ°°×³ýº¬ÓÐË«¾«°±ËáÐźÅëÄ(TatÐźÅëÄ)ÕâÒ»ÌØÐÔÍâ, »¹ÒÔÕÛµþµÄÐÎʽתÔË, δÕÛµþµÄÏß×´µ°°×ÖÊÔòͨ¹ýSecתÔËϵͳ¡£ ´ó³¦¸Ë¾úTatתÔËϵͳµÄ¹¦Äܵ¥Î»TatתÔËøÓÉÈýÖÖTatµ°°×(TatA¡¢ TatB ºÍTatC)×é³É¡£ µ°°×ÖÊÐòÁзÖÎö±íÃ÷Tatµ°°×¶¼ÊÇ´©Ä¤µ°°×, ¾­ÃâÒß¹²³ÁµíʵÑé֤ʵÁËTatA¡¢ TatBºÍTatC¹²´æÓÚϸ°ûĤÉÏ, ·ÖÀëÁËTatABºÍTatABC¸´ºÏÌå[10¡«12]¡£ ²¢ÔÚÌåÍâ·´Ó¦ÌåϵÖÐ×é×°Á˾ßÓлîÐÔµÄTatABC¸´ºÏÌå[13]¡£ TatBºÍTatCÊÇTatתÔËøµÄÖØÒª³É·Ö, ½üÀ´µÄÑо¿»¹±íÃ÷TatCµÄ°±»ùËáÖÖÀàºÍ·Ö²¼¶ÔתÔ˹¦ÄÜÓÐ×ÅÖØÒªµÄÓ°Ïì[14¡«16]¡£ ÕâЩÑо¿½øÕ¹¶ÔTatתÔËϵͳµÄ½øÒ»²½Ñо¿ÎÞÒÉÓкܴóµÄ´Ù½ø×÷Óá£

×ÔTatתÔËϵͳ·¢ÏÖÒÔÀ´, ¶àÒÔÌìÈ»ÒÀ¿¿TatתÔËϵͳתÔ˵Äø×÷Ϊ±¨¸æµ°°×, Èç´ó³¦¸Ë¾úµÄÈý¼×°·»ù-N-Ñõ»¯Îﻹԭø[TMAO (trimethylamine N-oxide) reductase, TMAO»¹Ô­Ã¸]¡¢ Ç⻯ø-2(hydrogenase-2)µÈÑáÑõºôÎüø¡£ Ò»°ãͨ¹ýø»îÐÔ»òµ°°×ÖÊÓ¡¼£µÈ·½Ê½À´²â¶¨Ã¸µÄתÔËÓë·ñºÍתÔ˵ĶàÉÙ, µ«ÕâЩָ±ê»áÊÜø»îÐԲⶨÌõ¼þ¼°²â¶¨µÄÃô¸ÐÐԵȵÄÓ°Ïì¡£ ΪÁ˽¨Á¢¸üΪֱ½Ó¡¢ ·½±ãµÄ¼ì²âÊÖ¶Î, ³¢ÊÔÓú£¿ûºìɫӫ¹âµ°°×(DsRed2)ºÍˮĸÂÌɫӫ¹âµ°°×(GFP)×÷Ϊ±¨¸æµ°°×, ½«TMAO»¹Ô­Ã¸µÄÐźÅëÄ(TorA-RR)»ùÒòÓëÓ«¹âµ°°×»ùÒòÖØ×éÀ´Ñо¿Ï¸¾úµ°°×ÖÊTatתÔËϵͳ¡£ ÓÉÓÚÓ«¹âµ°°×ÕýÈ·ÕÛµþºó²ÅÄÜÐγÉÓ«¹â[17], ËùÒԿɸù¾ÝÓ«¹âµÄÓÐÎ޺ͷֲ¼È·¶¨Ó«¹âµ°°×µÄÕÛµþºÍתÔË×´¿ö; ͨ¹ý¶¨Á¿²â¶¨Ó«¹âµÄÇ¿ÈõÈ·¶¨TatתÔËϵͳµÄתÔËЧÂÊ, ´Ó¶øÃ÷È·Ó°ÏìתÔ˵ÄÒòËØ¡£

±¾Ñо¿±íÃ÷, Á¬½ÓÔÚTorA-RRÐźÅëÄÏÂÓεĺìɫӫ¹âµ°°×Ôڴ󳦸˾úÖÐËä¿ÉÕýÈ·ÕÛµþºó²úÉúºìɫӫ¹â, µ«²»ÄÜתÔËÖÁÖÜÖʿռ䡣 ¾­Í¬Ñù´¦ÀíµÄÂÌɫӫ¹âµ°°×¿ÉÕýÈ·ÕÛµþ, ²¢ÒÔÕÛµþÐÎʽÔÚTatµ°°×µÄ²ÎÓëÏÂתÔËÖÁÖÜÖʿռ䡣 ½øÒ»²½ÒÔÀµ°±Ëá(K)²»Í¬³Ì¶ÈµØÈ¡´úÐźÅëÄÖеľ«°±ËáÐγÉеÄÐźÅëÄ(TorA-KR, TorA-RKºÍTorA-KK), ÒÔÑо¿¾«°±Ëá¶ÔÂÌɫӫ¹âµ°°×תÔ˵ÄÓ°Ïì¡£ ·¢ÏÖתÔËЧÂÊÓëÈ¡´úµÄ¾«°±ËáλÖÃÓÐÒ»¶¨µÄÏà¹ØÐÔ¡£ ½Òʾ¾«°±ËáÊÇÂÌɫӫ¹âµ°°×¸ßЧÂÊתÔËËù±ØÐèµÄ, ¶øÇÒµÚ¶þ¸ö¾«°±Ëá±ÈµÚÒ»¸ö¾«°±Ëá¸üÖØÒª¡£ ÕâÖÖÒ»¼¶½á¹¹µÄ¸Ä±äµ¼Ö½鵼תÔ˹¦ÄܵĽµµÍ»òɥʧ, ˵Ã÷ÐźÅëÄÒ»¼¶½á¹¹µÄ±ä»¯¿ÉÄÜÓ°Ïì¸ß¼¶½á¹¹µÄÐγɼ°±»TatϵͳÓÐЧµØÊ¶±ð, ½ø¶øÓ°ÏìÆä¹¦ÄÜ¡£ ͬʱ, ÏÔʾTatÐźÅëĶԵ°°×ÖÊÕÛµþºÍתÔ˶¼ÓÐÖÁ¹ØÖØÒªµÄ×÷Óá£

 

1    ²ÄÁϺͷ½·¨(Materials and Methods)

1.1   ²ÄÁÏ

1.1.1       ¾úÖêºÍÖÊÁ£    ʵÑé¾úÖêTG1(¦¤(lac-pro)supE thi hsd¦¤5/ F¡¯traD36 proA+B+ lacZ¦¤M15)¡¢ MC4100A(F-¦¤(argF-lac)U169 araD139 rpsL150 thi flb5301 deoC1 ptsF25 relA1 ara+)¡¢ B1LKOA(ÈçͬMC4100A ¦¤tatC)¡¢ BODA(ÈçͬMC4100A ¦¤tatB)¡¢ ELV16A(ÈçͬMC4100A ¦¤tatA)ºÍCU164A(ÈçͬMC4100A secY39cs, zhd-33¡ËTn10)[18,19]¡£ ÖÊÁ£p-DsRed2(ampR, DsRed2)¹º×ÔClontech¹«Ë¾¡¢ pRR-DsRed2(ampR, DsRed2¿Ë¡ÓÚpRR-gfp)¡¢ pgfpmut2(ampR, gfp gene)[17]¡¢ pRR-colV (ampR, cvaC¿Ë¡ÓÚpBAD8730)[18]¡¢ pRR-gfp (ampR, gfp¿Ë¡ÓÚpRR-colV)¡¢ pRKgfp¡¢ pKRgfp¡¢ pKKgfp¡¢ pAR-gfp[18,19]¡£

1.1.2       ÅàÑø»ù    ²ÉÓÃLuria-Bertani (LB)ÅàÑø»ù, ±ØÒªÊ±Ìí¼Ó°±ÜÐÇàÃ¹ËØ(100 mg/L)(Amp)ºÍ°¢À­²®ÌÇ(2 g/L)(APA)»òÆÏÌÑÌÇ(2 g/L)(APG)¡£

1.1.3       Ö÷Òª»¯Ñ§ÊÔ¼Á       ÏÞÖÆÐÔÄÚÇÐø¡¢ T4Á¬½Óø¡¢ ¾ÛºÏøµÈ¹º×ÔRoche Molecular Biochemicals¹«Ë¾¡£

1.2   ·½·¨

1.2.1       ÅàÑøÌõ¼þ       ǰÅàÑøÈ¡µ¥Ò»¾úÂä½ÓÖÖÓÚ4¡«5 mL LB»òAPGÅàÑø»ùÖÐ, 37 ¡æ¡¢ 120 r/minÕñµ´ÅàÑø¹ýÒ¹»òÖÁA600Ϊ0.6ʱ, 100±¶Ï¡Êͺó½øÐÐÀ©´óÅàÑø¡£

1.2.2       ¿¹°¢À­²®ÌǾúÖêµÄɸѡ       ½«´ý´¦Àí¾úÍ¿²¼ÓÚº¬Êïºì´Î¼×»ùÀ¶(EMB)ºÍ°¢À­²®ÌǵÄLBƽ°åÅàÑø»ùÉÏ, 37 ¡æ¹ýÒ¹ÅàÑø, ÌôÈ¡×ϺìÉ«µÄµ¥¾úÂä, ·ÖÀë´¿»¯¡£

1.2.3       ¿Ë¡ӫ¹âµ°°×»ùÒò       Ϊ¿Ë¡ÂÌɫӫ¹âµ°°×»ùÒò, Éè¼ÆÒýÎïΪ£º gfp up (5¡ä-aag aag gag ata taa cat gca gca aag gag-3¡ä), gfp down (5¡ä-tga cca tga agc ttg cat gcc tgc-3¡ä), ²¢ÔÚÉÏÏÂÓηֱðÒýÈëÁËNheI, pstIºÍHindIIIøÇÐλµã¡£ Ϊ¿Ë¡ºìɫӫ¹âµ°°×»ùÒò, Éè¼ÆÁËÒýÎ DsRed2 up (5¡ä-tcg cca cca tgg cta gct ccg aga acg tca-3¡ä), DsRed2 down (5¡ä-cta tta ggc ttg act gca gac aag ttg gta-3¡ä), ²¢ÔÚÉÏÏÂÓηֱðÒýÈëÁËNheI, NotIøÇÐλµã¡£ ÒÔÉÏÒýÎï¾ùÓÉMWG-Biotech France¹«Ë¾ºÏ³É¡£ ²ÉÓÃExpand high fidelity PCR system (Roche Molecular Biochemicals)ÔÚÌݶÈPCRºÏ³ÉÒǺϳɡ£ øÇмø¶¨À©ÔöƬ¶Î¡£

1.2.4       À©ÔöƬ¶ÎµÄ»ùÒò¿Ë¡ºÍÐòÁзÖÎö       ÂÌɫӫ¹âµ°°×»ùÒòPCR²úÎï¾­´¿»¯ºó, ÓÃNheIºÍHindIIIøÇкó¿Ë¡µ½ÖÊÁ£pRR-colVÏàӦλµã¡£ ºìɫӫ¹âµ°°×»ùÒòPCR²úÎï¾­´¿»¯ºó, ÓÃNheIºÍNotIøÇкó¿Ë¡µ½ÖÊÁ£pRR-gfpÏàӦλµã, Á¬½Óת»¯TG1ºó, ÔÚAPAƽ°åÉÏÅàÑø¹ýÒ¹, ÔÚ×ÏÍâµÆÏÂÑ¡Ôñ·¢Ó«¹âµÄ¾úÂä, ÌáÈ¡ÖÊÁ£, øÇмø¶¨, DNAÐòÁвⶨÓÉMWG-Biotech France¹«Ë¾²â¶¨¡£

1.2.5       pRR-gfpºÍpRR-DsRed2ת»¯      ת»¯pRR-gfpºÍpRR-DsRed2µ½MC4100A¼°¸÷tat»ùÒòȱÏÝÖêB1LKOA¡¢ BODA¡¢ ELV16AºÍSecY»ùÒòȱÏÝÖêCU164AÖС£ ÏÔ΢¾µ¹Û²ìÓ«¹â·Ö²¼²¢ÓÃCCDÏà»ú(Color Cool Viw, Photomic Sciences)ÉãÏñ²¢´¦Àí(Image Pro-Plus software)¡£

1.2.6       ϸ°û¸÷×é·ÖµÄÖÆ±¸       ϸ°ûÅàÑøÈçǰ, Ìí¼Ó0.2%°¢À­²®ÌÇÓÕµ¼Ó«¹âµ°°×»ùÒò±í´ï¡£ ÊÕ»ñϸ°û²ÉÓÃÈܾúø-EDTA-±ùË®ÉøÍ¸Ñ¹´¦Àí[3], »ñµÃϸ°ûÖÜÖʿռä³É·Ö, ÔÙÓÃFrench Press·¨µÃµ½Ï¸°ûÖʳɷ֡£

1.2.7       µçÓ¾       10%¾Û±ûÏ©õ£°·Äý½ºµçÓ¾40 mA¡¢ 40 min¡£

1.2.8       ¶¨Á¿²â¶¨Ó«¹âµ°°×µÄÇ¿¶È    ÖÆ±¸Ï¸°ûÖÜÖʿռäºÍϸ°ûÖʳɷÖ, ¾­»îÐÔÄý½ºµçÓ¾ºó, ¶¨Á¿²â¶¨Ï¸°û²»Í¬×é·ÖÖеÄÓ«¹âÁ¿(Spex Fluorolog III Ó«¹âÒÇ)¡£

 

2    ½á¹û(Results)

2.1   ¿¹°¢À­²®ÌǾúÖêµÄɸѡ

ÒòΪtorA-gfpÖØ×é»ùÒòµÄ±í´ïÊÜ¿ØÓÚ°¢À­²®ÌÇÆô¶¯×Ó, µ«araDȱÏݾúÖê·Ö½â°¢À­²®ÌÇ»á²úÉúÓꦵÄÖмä´úлÎï¡£ ÔÚEMB-°¢À­²®ÌÇÆ½°åÉÏɸѡÁË¿¹°¢À­²®ÌÇ´úлµÄ×ϺìÉ«MC4100A¡¢ B1LKOA¡¢ CU164A¡¢ BODAºÍELV16A¾úÖê¡£ ¸÷¾úÖêÔÚº¬°¢À­²®ÌǵÄÅàÑø»ùÉÏÉú³¤Õý³£¡£

2.2   Ó«¹âµ°°×»ùÒòÀ©Ôö²úÎïµÄ¿Ë¡¼°ÐòÁзÖÎö

º£¿ûºìɫӫ¹âµ°°×»ùÒòºÍˮĸÂÌɫӫ¹âµ°°×»ùÒòµÄPCRÀ©Ôö²úÎᆳøÇкóÓëÏàÓ¦ÔØÌåÁ¬½Ó, ¾­°±ÜÐÇàÃ¹ËØ¿¹ÐԺͱíÐÍɸѡºó, ·Ö±ðÌáÈ¡ÖÊÁ£²¢Ã¸Çмø¶¨, µÃµ½¶þ¸öÓëÏàÓ¦Ó«¹âµ°°×»ùÒòƬ¶Î´óСÏàËÆµÄƬ¶Î(0.69 kbºÍ0.73 kb), ÐòÁвⶨµÄ½á¹û½øÒ»²½ËµÃ÷Ä¿µÄ»ùÒòÒѿˡÓÚÔØÌåÖС£ ÖØ×éÖÊÁ£·Ö±ðÃüÃûΪpRR-DsRed2ºÍpRR-gfp¡£

2.3   Ó«¹âµ°°×ÔÚ²»Í¬Ï¸°ûÖеķֲ¼

½«ËùµÃµÄÖØ×éÖÊÁ£pRR-gfpºÍpRR-DsRed2·Ö±ðת»¯MC4100A¡¢ CU164A¡¢ B1LKOA¡¢ BODAºÍELV16A¸÷¾ú, µÃµ½ÁËһϵÁеÄת»¯×Ó¡£ ¾­´¿»¯·ÖÀë, ÅàÑøºóÌáÈ¡ÖÊÁ£, ·Ö±ðÓÃNheIºÍHindIIIøÇС¢ NheIºÍNotIøÇмø¶¨, È·¶¨º¬ÓÐÏàÓ¦µÄÓ«¹âµ°°×»ùÒò¡£ ¾­°¢À­²®ÌÇÓÕµ¼ÅàÑø, Ó«¹âµ°°×»ùÒòÔÚ¸÷¾úÖêÖоùÄܱí´ï¡£ ÔÚMC4100A/pRR-DsRed2ºÍB1LKOA/pRR-DsRed2ϸ°ûÖÐÖ»Äܹ۲쵽ºìɫӫ¹âµã(ͼ1)¡£ ´Ë½á¹û±íÃ÷ËäÈ»DsRed2ÈܽâÐÔ½ÏDsRedÓÐËùÌá¸ß, µ«ÊǺìɫӫ¹âµ°°×ÈÔ¾Û¼¯ÔÚϸ°ûÄÚ²»Äܱ»ÊäËͳöÈ¥¡£ Óë´ËÏà·´, ÔÚÒ°ÉúÐ;úMC4100A/pRR-gfpϸ°ûÍâΧÓÐÒ»Ã÷ÏÔµÄÂÌɫӫ¹â¹â»·, ¶øÔÚtat»ùÒòÍ»±äÖêELV16A/pRR-gfp(¦¤tatA)¡¢ BODA/pRR-gfp(¦¤tatB)ºÍB1LKOA/pRR-gfp(¦¤tatC)ÖÐ, ÂÌɫӫ¹âÖ»ÊǾùÔÈ·Ö²¼ÔÚÕû¸öϸ°ûÖÐ, ÇÒϸ°û³É¶Ô»ò³Ê¶ÌÁ´ÏàÁ¬²»·ÖÀë(ͼ2)¡£

Fig.1       Synthesis and distribution of red fluorescent protein fused to the TorA-RR signal peptide in the wild type (WT) strain and the ¦¤tatC mutant

Fig.2       Synthesis and distribution of green fluorescent protein fused to the TorA-RR signal peptide in the wild type strains and the ¦¤tat mutants

 

2.4   ÂÌɫӫ¹âµ°°×µÄתÔË

ÖÆ±¸Ï¸°ûÖÜÖʿռäºÍϸ°ûÖÊÌáȡҺ, ½øÐлîÐÔ¾Û±ûÏ©õ£°·Äý½ºµçÓ¾¡£ ½á¹ûÏÔʾMC4100AºÍCU164A¾úÖêµÄϸ°ûÖÜÖʿռäÌáȡҺÓÐÂÌɫӫ¹âµ°°×Ìõ´ø; µ«¶ÔÓÚB1LKOAºÍBODA¾úÖêÖ»ÔÚϸ°ûÖÊÌáȡҺÖÐÓÐÓ«¹âµ°°×Ìõ´ø, ÔÚÖÜÖʿռäÌáȡҺÖÐûÓÐÓ«¹âµ°°×Ìõ´ø(ͼ3)¡£ ÔÚϸ°ûÖÊÌáȡҺÖÐÂÌɫӫ¹âµ°°×ÊÇÒÔ´øÓÐÐźÅëĵÄǰÌåÐÎʽ´æÔÚ, ¶øÔÚϸ°ûÖÜÖʿռäÖÐÓÉÓÚÂÌɫӫ¹âµ°°×תÔ˺óÐźÅëı»Çгý, ËùÒÔÂÌɫӫ¹âµ°°×µÄ·Ö×Ó´óСÓвîÒì¡£

Fig.3       Translocation of the green fluorescent protein in the wild type strains and the tat mutants

Strains were separated on 10% native polyacrylamide gels and inspected under UV lamp. (A) Wild type strain (WT). (B) secY. (C) ¦¤tatC. (D) ¦¤tatB. 1, fractions of cytoplasm; 2, fractions of periplasm.

 

2.5   ÐźÅëÄÖÐË«¾«°±Ëá¶ÔÂÌɫӫ¹âµ°°×תÔ˵ÄÓ°Ïì

ͨ¹ýÓ«¹â·Ö¹â¹â¶È¼Æ²â¶¨Ï¸°ûÖÊÄÚ(ͼ4, °×É«¿é´ø)ºÍÖÜÖʿռäÖÐ(ºÚÉ«¿é´ø)µÄÂÌɫӫ¹âÇ¿¶È, ½á¹û±íÃ÷È¡´úÁ˱£ÊØÐòÁÐÖеIJ»Í¬Ë«¾«°±ËáÐγɵÄÐźÅëÄTorA-KK, TorA-KRºÍTorA-RK½µµÍÁËÓ«¹âµ°°×µÄתÔËЧÂÊ¡£ µÚ¶þλ¾«°±ËáµÄÈ¡´ú±ÈµÚһλ¾«°±ËáµÄÈ¡´úµÄ¸º×÷Óôó, Íêȫȡ´úÔò²»½éµ¼ÂÌɫӫ¹âµ°°×µÄתÔË¡£ ´ËÍâ, TorA-KR, TorA-RKºÍTorA-KK×ÜÌåÓ«¹âÁ¿½ÏTorA-RR×ÜÌåÓ«¹âÁ¿Öð½¥ÓÐËùϽµ¡£

Fig.4       Effect of twin arginine motif substitutions on the translocation of GFP in the wild type strain

Fluorescences of GFP in the periplasm (¡ö) and in the cytoplasm (¡õ) were quantified by Spex Fluorolog III. The arbitrary units of fluorescence were indicated.

 

3    ÌÖÂÛ(Discussion)

3.1   ×÷Ϊϸ¾úTatתÔËϵͳ±¨¸æµ°°×µÄÍâÔ´Ó«¹âµ°°×ÐÔÖÊÉÏÓвîÒì

ͨ¹ýʵÑéÖ¤Ã÷²»Í¬µÄÍâÔ´Ó«¹âµ°°×ÓÉÓÚÆä×ÔÉíÐÔÖʵIJîÒì, ÔÚ×÷Ϊϸ¾úTatתÔËϵͳµÄ±¨¸æµ°°×ʱ±íÏÖ³ö²»Í¬µÄ½á¹û¡£ ÔÚÒ°ÉúÐÍMC4100AºÍCU164A¾úÖêÖÐ, ÂÌɫӫ¹âµ°°×¿ÉÒÔתÔËÖÁÖÜÖʿռäÒÔ³ÉÊìÐÎʽ´æÔÚ[ͼ3(A), (B)]¡£ ¶øÔÚ¸÷tat»ùÒòȱÏÝÖêB1LKOAºÍBODAÖÐÂÌɫӫ¹âµ°°×½öÒÔǰÌåµÄÐÎʽ´æÔÚÓÚϸ°ûÖÊÖÐ, ûÓÐתÔ˵½ÖÜÖʿռä[ͼ3(C), (D)], Õâ˵Ã÷ÂÌɫӫ¹âµ°°×Ôڴ󳦸˾úÖпÉÕýÈ·ÕÛµþ, ²¢ÔÚtatBºÍtatC»ùÒò²úÎïµÄ¹²Í¬²ÎÓëÏÂתÔË, ÓëSecϵͳÎ޹ء£ Òò¶ø¿É×÷ΪTatתÔËϵͳµÄ±¨¸æµ°°×[19]¡£ º£¿ûºìɫӫ¹âµ°°×Ëä¿ÉÕýÈ·ÕÛµþ·¢³öºìɫӫ¹â, µ«²»ÄÜתÔË¡£ »îÐÔÄý½ºµçӾʵÑé±íÃ÷, ÔÚMC4100A¾úÖêºÍtat»ùÒòȱÏÝÖêϸ°ûÖʳéÌáÒºÖоùÓкìɫӫ¹âµ°°×Ìõ´ø, µ«ÖÜÖʿռä³éÌáÒºÖÐÎÞºìɫӫ¹âµ°°×Ìõ´ø(ͼδÏÔʾ), ÕâÒ»½á¹ûÓëÏÔ΢¾µ¹Û²ì½á¹ûÒ»Ö¡£ ÂÌÉ«ºÍºìɫӫ¹âµ°°×ÐòÁоßÓÐ23%ͬһÐÔ, ·Ö×Ó´óС½üËÆ(·Ö×ÓÁ¿·Ö±ðΪ27 kDºÍ28 kD), Èýά¿Õ¼ä½á¹¹Ïàͬ[20]¡£ ÓÈÆäÖØÒªµÄÊÇÁ½ÕßÓ«¹â»ùÍŶ¼ÊÇÔÚµ°°×ÕÛµþºó, ÓÉ3¸ö°±»ùËáͨ¹ý×ÔÎÒ´ß»¯Ñõ»¯·´Ó¦Ðγɻ·×´½á¹¹¶ø²úÉúµÄ¡£ ÂÌɫӫ¹âµ°°×ÒÔµ¥ÌåÐÎʽ´æÔÚ, ¶øºìɫӫ¹âµ°°×ÔòΪËľÛÌå²¢Ò×ÓÚ¾Û¼¯[21], ÒÔÖÂÓÚÔÚ°ûÄÚ¾ÛºÏÐγɴó·Ö×Ó¶ø²»ÄÜתÔ˶ø»ý¾ÛÔÚϸ°ûÖÊÖС£ ´Ó¶øÒ²ËµÃ÷ÁËתÔËͨµÀµÄ´óСÊÇÒ»¶¨µÄ, ²»ÔÊÐíÌ«´óµÄ·Ö×Óͨ¹ý¡£ ¹Êºìɫӫ¹âµ°°×²»ÒË×÷Ϊ±¨¸æµ°°×¡£

3.2   Ë«¾«°±ËáÊÇÂÌɫӫ¹âµ°°×¸ßЧÂÊתÔËËù±ØÐèµÄ

ÔçÆÚµÄÑо¿±íÃ÷TatÐźÅëĵÄË«¾«°±Ëá¶Ôµ°°×ÖÊ×